INTRODUCTION AND OBJECTIVES: Multiparametric magnetic resonance imaging (mpMRI) misses the diagnosis of part of clinically significant prostate cancer (csPCa). 68Ga-labeled PSMA positron emission tomography (68Ga-PSMA PET/CT) has been recently investigated as a first line diagnostic tool. This study was designed to explore whether 68Ga-PSMA PET/CT or the combination of mpMRI and 68Ga-PSMA PET/CT (MRI/PET) can improve the detection of csPCa.
METHODS: We retrospectively enrolled 54 patients who underwent both mpMRI and 68Ga-PSMA PET/CT before radical prostatectomy. Regions of interest (ROI) on imaging from mpMRI, 68Ga-PSMA PET/CT and pathology were marked. A lesion was defined when ROI was marked in the same location on continuous imaging at any of the imaging setting. All lesions were recorded by PI-RADS scoring, Mi-ES scoring and pathology results and analyzed. The diagnostic performance was analyzed by receiver operating characteristics (ROC) analysis. Specific improvement for lesions with different PI-RADS score and were analyzed by net reclassification improvement (NRI).
RESULTS: Totally, 90 lesions from 54 patients were analyzed, among which 66 lesions were csPCa. ROC analysis showed improvement of MRI/PET comparing with mpMRI for csPCa detection (DAUC 0.06; 95% CI, 0.01e0.12; p<0.05). With calculated cutoff, MRI/PET has a significant overall improvement compared with mpMRI (NRI, 21.9%, p<0.01), with an improvement on sensitivity (89% versus 76%, p<0.01) and no sacrifice on specificity (96% versus 88%, p>0.05). Diagnostic improvement for csPCa detection happened on lesions with PI-RADS 3 (NRI 66.7%, P<0.01).
CONCLUSIONS: The combination of 68Ga-PSMA PET/CT and mpMRI improves the detection of csPCa for lesions with PI-RADS 3.
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